Zenas Biopharma Inc Share Price

NASDAQ: ZBIO

Small Cap

$20.26

+0.09

(+0.45%)

as on September 13, 2025 at 1:29 am IST

$₹

Zenas Biopharma Inc Stock Performance

as on September 13, 2025 at 1:29 am IST

Day's Low
Day's High
$19.8
Day's Price Range
$21.72
$20.26
2.27%
Downside
7.21%
Upside
52 Week's Low
52 Week's High
$5.83
52-Week Price Range
$26.25
$20.26
71.22%
Downside
29.57%
Upside

Zenas Biopharma Inc share price movements today

Previous Close: $20.17
Open: $20.55
Volume: 872.0K
Day's Low - High: $19.8 - $21.72
52 Week Low - High: $5.83 - $26.25

Zenas Biopharma Inc Historical Returns

1 Month Return: + 21.07 %
3 Month Return: + 95.84 %
1 Year Return: + 11.46 %
3 Year Return: 0 %
5 Year Return: 0 %

Zenas Biopharma Inc Stock Fundamentals & Key Indicators

Check Zenas Biopharma Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$849.4M

EPS (TTM)

-1.35

Dividend Yield

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

Return On Equity TTM

2232400.00%

Zenas Biopharma Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Zenas Biopharma Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Zenas Biopharma Inc	NA	$849.4M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	280.5%	-505.15	-12.96%
Beone Medicines Ltd	NA	$37.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.2B	54.04%	28.08	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.4B	2.03%	14.11	31.37%

Stock Returns calculator for Zenas Biopharma Inc Stock including INR - Dollar returns

The Zenas Biopharma Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Zenas Biopharma Inc investment value today

Current value as on today

₹1,16,764

Returns

₹16,764

(+16.76%)

Returns from Zenas Biopharma Inc Stock

₹11,625 (+11.63%)

Dollar Returns*

₹5,139 (+5.14%)

Zenas Biopharma Inc Stock's Interest Amongst Investors

Search interest for Zenas Biopharma Inc Stock has increased by 217% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 15, 2025 to September 14, 2025

Change:217% versus previous 30 day period

Zenas Biopharma Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	50	-	-	-	-	5	10	-
Gross Profit	50	-20	0	0	0	5	10	0
Operating Income	35	-24	-27	-39	-40	-55	-37	-55
EBITDA	35	-24	-27	-39	-40	-55	-33	-55
Interest Expense	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0
Income Before Tax	35	-24	-27	-37	-38	-52	-33	-52
Income Tax Expense	-	0	-	-	-	0	0	0
Net Income	35	-24	-27	-37	-38	-52	-33	-52
Net Profit Margin	71.22%	0.00%	0.00%	0.00%	0.00%	-1052.08%	-335.73%	0.00%

Zenas Biopharma Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	50	5
Gross Profit	0	50	5
Operating Income	-76	-37	-163
EBITDA	-75	-27	-163
Interest Expense	-	-	-
Depreciation	0	0	0
Income Before Tax	-119	-36	-156
Income Tax Expense	-	0	0
Net Income	-119	-37	-156
Net Profit Margin	0.00%	-74.25%	-3139.76%

Zenas Biopharma Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-29	35	-24	-27	-37	-38	-52	-33	-52
Operating Cash Flow	-20	31	-15	-19	-30	-31	-38	-37	-41
Investing Cash Flow	-	-	0	0	0	-26	-3	-86	-112
Financing Cash Flow	0	20	0	0	177	233	1	0	1
Change in Cash	-20	51	-15	-19	146	176	-40	-123	-152

Zenas Biopharma Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2023	Dec 2024
Net Income	-37	-156
Operating Cash Flow	-30	-119
Investing Cash Flow	0	-30
Financing Cash Flow	20	412
Change in Cash	-10	262

Insights on Zenas Biopharma Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 month, ZBIO stock has moved up by 20.8%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.7% return, outperforming this stock by 64.5%

About Zenas Biopharma Inc

Zenas BioPharma, Inc. is a clinical-stage global biopharmaceutical company focused on the development and commercialization of transformative therapies for patients with autoimmune diseases. The Company's lead product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are broadly present across B cell lineage, to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them. The Company is developing obexelimab as a potential immunology and inflammation (I&I) franchise for patients in several autoimmune diseases. The first three indications it is pursuing include immunoglobulin G4-related disease (IgG4-RD), relapsing multiple sclerosis (RMS) and systemic lupus erythematosus (SLE). Its other programs include ZB002 (an anti-TNFα monoclonal antibody), ZB004 (a CTLA-4-Ig fusion), and ZB001 and related programs. ZB002 is a recombinant human monoclonal antibody directed at human TNFα.

Organisation	Zenas Biopharma Inc
Headquarters	852 Winter Street, Waltham, MA, United States, 02451
CEO	Mr. Leon Oliver Moulder Jr., M.B.A.
E-voting on shares	Click here to vote

Key Management of Zenas Biopharma Inc

Name	Title
Dr. Lisa von Moltke M.D.	Head of Research & Development and Chief Medical Officer
Mr. Leon Oliver Moulder Jr., M.B.A.	CEO & Chairman of the Board
Mr. Joseph L. Farmer	COO & President
Mr. Orlando Oliveira	Chief Commercial Officer
Dr. Haley Laken Ph.D.	Chief Scientific Officer
Mr. Jeffrey Held	Chief Legal Officer
Dr. Tanya Z. Fischer M.D., Ph.D.	Head of Research & Development and Chief Medical Officer.
Ms. Jennifer A. Fox	Chief Business Officer & CFO
Ms. Caroline Chevalier	Chief Human Resources Officer

FAQs

What is Zenas Biopharma Inc share price today?

Zenas Biopharma Inc share price today is $20.26 as on September 13, 2025 at 1:29 am IST at the close of the market. Zenas Biopharma Inc share today touched a day high of $21.72 and a low of $19.8.

What is the 52 week high and 52 week low for Zenas Biopharma Inc share?

Zenas Biopharma Inc share touched a 52 week high of $26.25 on October 23, 2024 and a 52 week low of $5.83 on January 28, 2025. Zenas Biopharma Inc stock price today i.e. September 13, 2025 at 1:29 am IST is closed at $20.26,which is 22.82% down from its 52 week high and 247.51% up from its 52 week low.

What is Zenas Biopharma Inc's market capitalisation today?

Zenas Biopharma Inc market capitalisation is $0.00T as on September 13, 2025 at 1:29 am IST.

How to invest in Zenas Biopharma Inc Stock (ZBIO) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Zenas Biopharma Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Zenas Biopharma Inc Shares that will get you 0.0740 shares as per Zenas Biopharma Inc share price of $20.26 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Zenas Biopharma Inc Stock (ZBIO) from India?

Indian investors can start investing in Zenas Biopharma Inc (ZBIO) shares with as little as ₹88.27 or $1 (as of September 14, 2025 at 4:37 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Zenas Biopharma Inc stock (as per the Rupee-Dollar exchange rate as on September 14, 2025 at 4:37 am IST). Based on Zenas Biopharma Inc share’s latest price of $20.26 as on September 13, 2025 at 1:29 am IST, you will get 0.4936 shares of Zenas Biopharma Inc. Learn more about fractional shares .